Loading...

Wechat

Website

Table of Content

    25 December 2017, Volume 9 Issue 6 Previous Issue    Next Issue
    Treatment strategies for management of small hepatocellular carcinoma
    Zhang Yaojun,Chen Minshan
    2017, 9 (6):  423-426.  doi: 10.3969/j.issn.1674-5671.2017.06.01
    Abstract ( 326 )   PDF (474KB) ( 417 )   Save
    Related Articles | Metrics
    Hepatectomy to treat liver tumors situated in or involving the caudate lobe
    Lin Hui,Yang Yuan,Yuan Peihua,Liu Hui,Pan Zeya,Huang Gang,Lin Chuan,Zhou Weiping
    2017, 9 (6):  427-432.  doi: 10.3969/j.issn.1674-5671.2017.06.02
    Abstract ( 410 )   PDF (556KB) ( 461 )   Save
    Related Articles | Metrics
    Effect of Eosinophils in peripheral blood on prognosis after hepatectomy  for hepatocellular carcinoma
    Zhang Jie,Qi Yapeng,Chen Bin,Lu Fei,Yuan Weiping,Ma Liang,Li Lequn,Xiang Bangde
    2017, 9 (6):  447-451.  doi: 10.3969/j.issn.1674-5671.2017.06.06
    Abstract ( 340 )   PDF (446KB) ( 297 )   Save

    Objective To investigate the significance of increased eosinophils (EOS) in peripheral blood on the prognosis after radical resection for hepatocellular carcinoma(HCC),providing a reference for determining the prognosis of patients after radical resection for liver cancer. Methods Clinical data were retrospectively analyzed for patients with newly diagnosed HCC undergoing radical hepatectomy in Affiliated Tumor Hospital Guangxi Medical University between January 2011 and December 2013.Patients (431) were divided into 2 groups: a group that showed preoperative EOS increase (n=56),and a group that showed normal EOS (n=375). Imbalance in clinical data between the two groups was eliminated using propensity score matching(PSM).Survival analysis was conducted using the Kaplan-Meier method. Independent risk factors for cumulative survival rate were determined using Cox proportional hazards modeling. Results Before PSM,cumulative survival rates at 1,3 and 5 years were 78.9%,54.3%,and 38.0% in the normal EOS group;the corresponding values in the EOS increase group were 82.1%,49.9%,and 30.1%(χ2=0.614,P=0.341).After PSM(1∶1),47 patient pairs were obtained,and the cumulative survival rates were 85.1%,61.6%,and 31.2% in the normal EOS group,compared to 87.2%,50.0%,and 25.1% in the EOS increase group (χ2=0.601,P=0.438). Conclusion Preoperative increase in EOS in peripheral blood has no effect on overall survival rate in HCC patients.

    Related Articles | Metrics
    Comparison of ethanol injection combined with transcatheter arterial chemoembolization or ethanol injection alone for treatment of small hepatocellular carcinoma
    Li Guanghui,Liu Yayun,Peng Tao,Shang Liming,Chen Bin,Su Hao,Zhu Guangzhi,Ye Xinping
    2017, 9 (6):  452-455.  doi: 10.3969/j.issn.1674-5671.2017.06.07
    Abstract ( 326 )   PDF (456KB) ( 430 )   Save

    Objective To compare ethanol injection with or without transcatheter arterial chemoembolization(TACE) for treating small hepatocellular carcinoma. Methods Clinical data of 50 patients with small hepatocellular treated at our hospital from October 2008 to November 2014 were retrospectively analyzed. Patients were treated with ethanol injection combined with TACE(n=41) or with ethanol injection alone(n=9). The two groups were compared in terms of alpha fetoprotein(AFP) negative rate,AFP decrease rate,and survival rates at 1,2,and 3 years. Results In the combination treatment group,the AFP negative rate was 66.67%,the AFP decrease rate was 90.48%,and survival rates were 87.80% at 1 year,80.49% at 2 years and 75.61% at 3 years. The corresponding results for the ethanol-only group were 14.29%,71.43%,77.78%,55.56% and 33.34%.The combination group showed higher AFP negative rate and higher 3-year survival rate than the ethanol-only group. Conclusions Ethanol injection with TACE is superior to ethanol injection alone for small hepatocellular carcinoma,so it should be considered as a valuable treatment against this disease.

    Related Articles | Metrics
    Effect of NK4 gene expression combined with oxaliplatin on apoptosis and invasion by human colorectal cancer HCT116 cells
    Yang Liuting,Jiang Penglei,Zu Dandan,Li Meining,Zhang Dong,Chang Bingmei
    2017, 9 (6):  456-461.  doi: 10.3969/j.issn.1674-5671.2017.06.08
    Abstract ( 375 )   PDF (941KB) ( 421 )   Save

    Objective This study explored the effect of NK4 expression combined with oxaliplatin on apoptosis and invasion by human colorectal cancer cells(HCT116). Methods An expression plasmid encoding the NK4 gene was built and transfected into HCT116 cells by Effectene transfection.The influence of NK4 associated with oxaliplatin on apoptosis was analyzed by flow cytometry,and the influence on invasion was analyzed by the transwell chamber method.Interaction of NK4 and oxaliplatin was evaluated using the Q value method of Zhengjun Jin.Western blotting was used to detect changes in levels of p-Akt with different drug stimulation. Results The NK4 expression plasmid was successfully built and transfected into HCT116 cells,and expression of the target gene was significantly higher than in the negative control group and blank group(P<0.01).Compared with the negative control group,NK4 expression combined with oxaliplatin significantly promoted apoptosis (16.55% vs 46.86%,P<0.05) and significantly inhibited cell invasion (0.9% vs 77.4%,P<0.05).The Q value method indicated that the combined treatment had a synergistic effect on apoptosis and invasion (0.85≤Q<1.15).Expression of the apoptosis-and invasion-related protein p-Akt was significantly down-regulated in the combination group,which showed synergistic inhibition(P<0.01). Conclusions NK4 expression combined with oxaliplatin can synergistically induce apoptosis and inhibit invasion by HCT116 cells via the Akt signaling pathway.

    Related Articles | Metrics
    Incidence and mortality of liver cancer in areas with cancer registration in Guangxi,2013
    Li Qiulin,Yu Jiahua,Rong Minhua,Cao Ji,Ge Lianying
    2017, 9 (6):  462-468.  doi: 10.3969/j.issn.1674-5671.2017.06.09
    Abstract ( 392 )   PDF (551KB) ( 332 )   Save

    Objective Analyze incidence of liver cancer and associated mortality in Guangxi in 2013 based on areas with cancer registry reporting. Methods In 2016,8 cancer registries of Guangxi reported cancer data for 2013,and 6 registries were found to conform to data quality criteria of the NCCR.Data from these 6 registries were analyzed to determine incidence and mortality of liver cancer stratified by areas(urban/rural),sex,age group and region.Proportions,cumulative incidence/mortality rates,and truncated incidence/mortality rates were calculated.The Chinese population census in 2000 and Segi's population were used for age-standardized incidence/mortality rates. Results All 6 cancer registries covered a total population of 5,196 ,871(1,933,143 in urban areas,3,263,728 in rural areas).The total number of new cases of liver cancer was 2,165,and the number of liver cancer-related deaths was 1,801.Morphology-verified cases accounted for 21.02%.Death certifications accounted for 2.54%. The ratio of mortality to incidence was 0.83.The crude incidence of liver cancer in China cancer registration areas was 41.66/105(males 64.07/105,females 17.42/105). Age-standardized incidence rates were 36.93/105 based on the Chinese standard population(ASR China) and 35.92/105 based on the world standard population (ASR world). Cumulative incidence rate (0-74 years old) was 4.01%,and the truncated incidence rate (35-64 years old) was 73.85/105. The proportion of liver cancer was 17.23%.The incidence of liver cancer and ASR China were 31.19/105 and 26.01/105 in urban areas,compared to 47.86/105 and 44.53/105 in rural areas. Crude mortality associated with liver cancer in Guangxi cancer registration areas was 34.66/105(males 54.67/105,females 13.02/105). Age-standardized mortality rates was 30.29/105 based on the Chinese standard population (ASR China) and 29.48/105 based on the world standard population (ASR world). Cumulative mortality rate (0-74 years old) was 3.23% and truncated mortality rate(35-64 years old) was 48.12/105.The proportion was 22.77%. Mortality associated with liver cancer and ASR China were 22.92/105 and 18.96/105 in urban areas,compared to 41.61/105 and 37.94/105 in rural areas.Conclusion In Guangxi,incidence of liver cancer and associated mortality are higher than the national level. Incidence and mortality of liver cancer in rural areas are higher than in urban areas. Incidence of liver cancer and associated mortality are higher in the south-central region than in the north-central region. Whether in urban or in rural areas,incidence and mortality are obviously higher in males than in females.

    Related Articles | Metrics
    Clinical significance of RAB22A expression in breast cancer
    Tang Xianghui,Tang Shicong,Zhang Fan,Yang Rirong,Zhang Qiong
    2017, 9 (6):  469-472.  doi: 10.3969/j.issn.1674-5671.2017.06.10
    Abstract ( 311 )   PDF (423KB) ( 447 )   Save

    Objective To research the clinical significance of RAB22A expression in breast cancer. Methods Real-time PCR analysis was used to assess the expression of RAB22A mRNA in 60 breast cancer tissues and adjacent non-cancer tissues. Results RAB22A mRNA was expressed at high levels in tumors and low levels in adjacent non-cancer tissues [(4.9±1.1) vs (1.1±0.3),P<0.01]. RAB22A expression did not vary significantly with age,tumor invasion depth,ER status,PR status or HER-2 status(P>0.05),but it did vary significantly with lymph node metastasis (P<0.05). High expression of RAAB22A and the number of ymph node metastasis correlated with poor survival(P<0.05). Conclusions RAB22A is expressed at high level in breast cancer tissue,and high expression correlates with poor survival of breast cancer patients.

    Related Articles | Metrics
    The effect of neoadjuvant chemotherapy on advanced gastric cancer surgery
    Long Pengchen,Huang Mingwei,Wu Liucheng,Chen Jiansi
    2017, 9 (6):  473-477.  doi: 10.3969/j.issn.1674-5671.2017.06.11
    Abstract ( 274 )   PDF (433KB) ( 369 )   Save

    Objective To explore the safety of neoadjuvant chemotherapy for advanced (stage Ⅲ) gastric cancer and its recent effi-cacy. Methods A total of 138 patients with locally advanced gastric cancer (stage Ⅲ) confirmed by Affiliated Tumor Hospital of Guangxi Medical University from March 2012 to March 2016 were divided into trial group(n=50) and control group(n=88). Patients in the trial group underwent both neoadjuvant chemotherapy and surgery,control patients underwent surgery and adjuvant chemotherapy. Surgical complications and recent efficacy were compared between the two groups. Results The median survival time was 36.9 months in trial group and 30.9 months in control group (P=0.317). The trial group showed lower recurrence rates of 12 months (34.0% vs 52.3%,P=0.038),and higher R0 resection rate(84.0% vs 68.2%,P=0.042). The two groups experienced similar major complications (P>0.05). The trial group showed more intraoperative blood transfusion, more intraoperative blood loss, longer operation time and more lymph node metastasis(P<0.05), and there was no difference between patients who underwent combined organ resection(P>0.05). Conclusion Neoadjuvant chemotherapy can improve the R0 resection rate,reduce recurrence rate of advanced gastric cancer,and is not a risk factor for surgical complications.

    Related Articles | Metrics
    Efficacy of celecoxib combined with chemotherapy in the treatment of advanced gastric cancer
    Gao Nana,Ma Xin,He Xin'ai
    2017, 9 (6):  478-481.  doi: 10.3969/j.issn.1674-5671.2017.06.12
    Abstract ( 377 )   PDF (429KB) ( 524 )   Save

     Objective To evaluate the therapeutic efficacy and toxicity of celecoxib plus docetaxel and S-1 in the treatment of advanced gastric cancer. Methods Fifty patients with advanced gastric cancer were randomly divided into two groups,which were treated with celecoxib (Celebrex) plus docetaxel and S-1 (n=25),or with docetaxel and S-1 (n=25) as the control arm. Results After treatment,the total effective rate and disease control rate were 60% and 96% in the treatment group,compared to 52% and 92% in the control group.The groups were similar in terms of total effective rate and disease control rate(P>0.05).Toxicity after treatment was minor in the two groups,and incidences of toxic events were similar between the two groups(P>0.05).Improvement in quality of life was significantly higher in the treatment group than in the control group (60% vs 32%,P<0.05).Median PFS was 7.6 months in the treatment group,which was significantly higher than 6.3 months in the control group(P<0.05).Median overall survival was 13.6 months in the treatment group and 12.2 months in the control group (P>0.05). Conclusions Celecoxib plus docetaxel and S-1 for advanced gastric cancer is superior to chemotherapy alone,and it can prolong PFS and improve quality of life without increasing adverse reactions.

    Related Articles | Metrics
    Relationship between DCE-MRI parameters and pathological staging in rectal cancer
    Xie Yu'en,Liao Jinyuan,Wang Zheng,Li Kunfang
    2017, 9 (6):  482-485.  doi: 10.3969/j.issn.1674-5671.2017.06.13
    Abstract ( 377 )   PDF (403KB) ( 385 )   Save

    Objective To investigate the correlation between 3.0T DCE-MRI parameters and pathological stage of rectal cancer,and to provide more valuable information for clinical improvement of preoperative diagnosis and prognosis of rectal cancer. Methods A total of 68 patients with rectal cancer were enrolled at our hospital from March 2015 to April 2016.The volume transfer constant(Ktrans),rate constant(Kep),and extravascular extracellular volume fraction(Ve)were measured,and time-signal intensity curves were plotted from the 3.0T MRI and processing station. The Ktrans,Kep,Ve values of different pathological stages of rectal cancer were com-pared,and potential correlations were explored. Results Ktrans differed significantly among pathological T stages(P<0.05),but Kep and Ve did not(P>0.05).Ktrans,Kep and Ve did not differ significantly among different stages of rectal cancer(P>0.05). The diagnostic threshold of the tumor Ktrans value was 0.869 min-1,which served as an indicator to determine whether T stage was early or late. Diagnostic sensitivity was 59.0% and specificity was 99.0%. The pathological T stage of rectal cancer showed a positive correlation with tumor Ktransr=0.403,P<0.01). Conclusions The T stage of rectal cancer positively correlated with tumor Ktrans. These DCE-MRI parameters can provide a meaningful reference value for preoperative diagnosis and clinical prognosis of rectal cancer.

    Related Articles | Metrics
    Imaging features of 3.0T MRI dynamic enhanced scanning and diffusion-weighted imaging in breast cancer 
    Zhao Qinping,Huang Ruisui,Liu Chunyu
    2017, 9 (6):  491-493.  doi: 10.3969/j.issn.1674-5671.2017.06.16
    Abstract ( 477 )   PDF (477KB) ( 432 )   Save

    Objective To investigate the imaging features of breast cancer in 3.0T MRI dynamic enhanced scanning and diffusion-weighted imaging (DWI). Methods 3.0T MRI imaging data were analyzed for 36 patients with breast cancer confirmed by surgery and pathology in our hospital. Results Breast cancer presented an equal or slightly lower signal based on normal MRI and T1-weighted imaging;it presented equal or slightly higher signal on T2-weighted imaging.Tumor shape was irregular and showed different depth leaflets,fuzzy boundaries,and visible spicule signs. DWI showed all lesions as presenting high signal,while ADC presented low signal. Dynamic enhancement led to uneven reinforcement and always presented as motting,strip or mass. Peripheral vascular shadow around the partial lesion was increased. The time-signal intensity curve showed a type Ⅲ curve in 29 cases (80.6%),a type Ⅱ curve in 5 cases (13.9%),and a typeⅠ curve in only 2 cases (5.5%). A total of 34 of 36 cases were correctly diagnosed as breast cancer,while the remaining 2 cases were misdiagnosed as fibroadenoma. The diagnostic coincidence rate was 94.4%. Conclusion 3.0T MRI dynamic enhanced scanning and DWI correlate well for diagnosis of breast cancer.

    Related Articles | Metrics
    Research progress in PD-1/PD-L1 expression in human solid tumors
    Fan Yu,Liu Bin,Yuan Huijun,Li Changtian,Qian Zhen
    2017, 9 (6):  498-501.  doi: 10.3969/j.issn.1674-5671.2017.06.18
    Abstract ( 300 )   PDF (357KB) ( 408 )   Save
    Related Articles | Metrics
    Research progress of the correlation between etiology and mechanism of thyroid carcinoma and breast carcinoma
    Liao Mange,Lv Chunyan,Zhang Lilin,Ren Yanxin,Li Xiaojiang
    2017, 9 (6):  501-505.  doi: 10.3969/j.issn.1674-5671.2017.06.19
    Abstract ( 461 )   PDF (366KB) ( 594 )   Save
    Related Articles | Metrics
    Progress in anti-tumor angiogenesis research with VEGF/VEGFR pathway as a target in advanced NSCLC
    Liao Mange,Lv Chunyan,Zhang Lilin,Ren Yanxin,Li Xiaojiang
    2017, 9 (6):  506-511.  doi: 10.3969/j.issn.1674-5671.2017.06.20
    Abstract ( 239 )   PDF (373KB) ( 1662 )   Save
    Related Articles | Metrics
    Single clear cell sarcoma of the right submandibular: case report
    Zhao Peng,Yang Jianbo,Xu Jian,Zeng Xianjie,Li Wei
    2017, 9 (6):  512-513.  doi: 10.3969/j.issn.1674-5671.2017.06.21
    Abstract ( 304 )   PDF (365KB) ( 288 )   Save
    Related Articles | Metrics